These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 16033251)
1. Molecular mechanisms for vascular injury in the metabolic syndrome. Yamagishi S; Nakamura K; Jinnouchi Y; Takenaka K; Imaizumi T Drugs Exp Clin Res; 2005; 31(3):123-9. PubMed ID: 16033251 [TBL] [Abstract][Full Text] [Related]
2. The metabolic syndrome, type 2 diabetes, and cardiovascular disease: understanding the role of insulin resistance. Kendall DM; Harmel AP Am J Manag Care; 2002 Dec; 8(20 Suppl):S635-53; quiz S654-7. PubMed ID: 12510788 [TBL] [Abstract][Full Text] [Related]
3. Mechanisms of hypertension in the cardiometabolic syndrome. Redon J; Cifkova R; Laurent S; Nilsson P; Narkiewicz K; Erdine S; Mancia G J Hypertens; 2009 Mar; 27(3):441-51. PubMed ID: 19262221 [TBL] [Abstract][Full Text] [Related]
8. Metabolic syndrome-interdependence of the cardiovascular and metabolic pathways. Caglayan E; Blaschke F; Takata Y; Hsueh WA Curr Opin Pharmacol; 2005 Apr; 5(2):135-42. PubMed ID: 15780821 [TBL] [Abstract][Full Text] [Related]
9. Hypertension in obese patients: a dysmetabolic hypertension with a possible adipocyte dysfunction mechanism. Blaj S; Stanciu S; Jurcut C; Ciobîcă L Rom J Intern Med; 2003; 41(2):103-11. PubMed ID: 15526495 [TBL] [Abstract][Full Text] [Related]
10. Metabolic syndrome. Vitale C; Marazzi G; Volterrani M; Aloisio A; Rosano G; Fini M Minerva Med; 2006 Jun; 97(3):219-29. PubMed ID: 16855517 [TBL] [Abstract][Full Text] [Related]
11. Cardiovascular risk in the spectrum of type 2 diabetes mellitus. Ahmed I; Goldstein BJ Mt Sinai J Med; 2006 Sep; 73(5):759-68. PubMed ID: 17008936 [TBL] [Abstract][Full Text] [Related]
12. Adipokines in diabetes and cardiovascular diseases. Kralisch S; Sommer G; Deckert CM; Linke A; Bluher M; Stumvoll M; Fasshauer M Minerva Endocrinol; 2007 Sep; 32(3):161-71. PubMed ID: 17912155 [TBL] [Abstract][Full Text] [Related]
13. Renin-angiotensin-aldosterone system intervention in the cardiometabolic syndrome and cardio-renal protection. Whaley-Connell A; Pavey BS; Chaudhary K; Saab G; Sowers JR Ther Adv Cardiovasc Dis; 2007 Oct; 1(1):27-35. PubMed ID: 19124393 [TBL] [Abstract][Full Text] [Related]
14. Adipocytokines and metabolic syndrome. Matsuzawa Y Semin Vasc Med; 2005 Feb; 5(1):34-9. PubMed ID: 15968578 [TBL] [Abstract][Full Text] [Related]
16. The role of the renin-angiotensin system in the pathophysiology, prevention, and treatment of renal impairment in patients with the cardiometabolic syndrome or its components. Alpert MA; Govindarajan G; Del Rosario ML; Reisin E J Cardiometab Syndr; 2009; 4(1):57-62. PubMed ID: 19245518 [TBL] [Abstract][Full Text] [Related]
17. Cardiovascular risk and adrenergic overdrive in the metabolic syndrome. Grassi G; Quarti-Trevano F; Seravalle G; Dell'Oro R Nutr Metab Cardiovasc Dis; 2007 Jul; 17(6):473-81. PubMed ID: 17451923 [TBL] [Abstract][Full Text] [Related]
18. Macrovascular complications of metabolic syndrome: an early intervention is imperative. Tenenbaum A; Motro M; Schwammenthal E; Fisman EZ Int J Cardiol; 2004 Nov; 97(2):167-72. PubMed ID: 15458679 [TBL] [Abstract][Full Text] [Related]
19. Abdominal obesity and metabolic syndrome. Després JP; Lemieux I Nature; 2006 Dec; 444(7121):881-7. PubMed ID: 17167477 [TBL] [Abstract][Full Text] [Related]
20. Diabetes is a vascular disease: the role of endothelial dysfunction in pathophysiology of cardiovascular disease in diabetes. Deedwania PC Cardiol Clin; 2004 Nov; 22(4):505-9, v. PubMed ID: 15501619 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]